证券代码：002980 证券简称：华盛昌 编号：2022-007 深圳市华盛昌科技实业股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|----------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------| | | √特定对象调研 □分析师会议 | | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | √其他（电话会议） | | | 参与单位名称及 人员姓名 | | 广发证券资管；国信证券；光大证券；方正富邦基金；中信建 投基金；壹帮友私募基金；海利祥资本；瀚信资产；美黎资产； | | | | | | 时间 | 君宇通资本；金麦粒。 2022 年 7 月 7 日 | | ...

Company Overview - Shenzhen Huashengchang Technology Industry Co., Ltd. has been deeply engaged in the instrument and measurement testing industry since its establishment in 1991, with extensive experience in product research and development [1] - The company specializes in core measurement technologies across various sectors, including electricity, electronics, environmental monitoring, medical, construction, automotive, and IoT [1] Financial Performance - In 2021, the company achieved a revenue of CNY 740.05 million, with a net profit of CNY 148.88 million, marking a year-on-year increase of 31.91% for non-epidemic products and a 46.64% increase compared to the same period in 2019 [2] - Overall revenue grew by 58.96% compared to 2019, and net profit increased by 63.68% [2] - The average gross margin for products was 40.25%, with a net profit margin of 20.12%, indicating strong profitability [2] Product Segmentation - **Electrical and Power Products**: Generated CNY 339.20 million in revenue, accounting for 45.84% of total revenue, with a growth of 23.82% from 2020 [2] - **Environmental Detection Products**: Achieved CNY 248.41 million in revenue, representing 33.57% of total revenue; infrared thermal imaging products saw over 200% growth compared to 2019 [2] - **Medical, Construction, and Automotive Products**: Contributed CNY 74.26 million, making up 10.03% of total revenue, with a 38.21% increase compared to 2020 [3] Technological Innovation - The company emphasizes R&D and has obtained 264 domestic and international patents, along with 17 software copyrights as of December 31, 2021 [3] - It focuses on smart, portable, and highly integrated measurement instruments, continuously enhancing its technological capabilities [3] Future Development Strategy - **Expansion into Medical Diagnostics**: The company is entering the IVD (in vitro diagnostics) market, leveraging its infrared temperature measurement technology to develop molecular diagnostic platforms and COVID-19 antigen testing kits [4] - **Sensor Module Development**: Plans to enhance sensor module applications based on 30 years of measurement technology experience, aiming to improve product offerings and reduce cost risks [4] - **Smart Wearable Devices**: The company is developing smart wearables that integrate measurement technologies for personal health management, with a focus on consumer electronics [5][6] Market Opportunities - The domestic market share for measurement instruments is increasing due to the push for domestic substitution policies, with the company's domestic revenue share reaching 10.02% in 2021, a 116.26% increase from 2019 [7] - The company aims to capitalize on the growing demand for domestic products and expand its market presence [7]

证券代码：002980 证券简称：华盛昌 深圳市华盛昌科技实业股份有限公司 投资者关系活动记录表 编号：2022-008 | --- | --- | --- | |-------------------------|--------------------------------|----------------------------------------------------------| | | □特定对象调研 √分析师会议 | | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | √其他（电话会议） | | | 参与单位名称及 人员姓名 | 德邦证券 | | | 时间 | 2022 年 9 月 19 日 | | | 地点 公司会议室 | | | | 上市公司接待人 员姓名 | 董事会秘书：任欢 | | | | 一、公司情况简介 公司成立 31 | 年以来，深耕仪器仪表测量测试行业的技术 | | | | 研发和产品制造，产品研发经验丰富，技术储备广泛，掌握了 | | | | 电力、电子、电工、环境、医疗、建筑 ...

证券代码：002980 证券简称：华盛昌 深圳市华盛昌科技实业股份有限公司 投资者关系活动记录表 编号：2022-009 | --- | --- | --- | |----------------|-----------------------------------|----------------------------------------------------------| | | √特定对象调研 □分析师会议 | | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 | | | 参与单位名称及 | | 安信证券；国投瑞银基金；中融基金；上海汐泰投资；长城基 | | 人员姓名 | 金 | | | 时间 | 2022 年 10 月 11 日 | | | 地点 | 公司会议室 | | | 上市公司接待人 | 董事长：袁剑敏 | | | 员姓名 | 董事会秘书：任欢 一、公司情况简介 | | | | 公司成立 31 | 年以来，深耕仪器仪表测量测试行业的技术 | | | | 研发和产品制造，产品研发经验丰 ...

证券代码：002980 证券简称：华盛昌 深圳市华盛昌科技实业股份有限公司 投资者关系活动记录表 编号：2022-010 | --- | --- | --- | --- | --- | |-------------------------|-----------------------------------------|--------------------------------------------------------|-------|--------------------------| | | | | | | | 投资者关系活动 | □ 特定对象调研 □ 媒体采访 □ | □ 分析师会议 业绩说明会 | | | | 类别 | □ 新闻发布会 □ | 路演活动 | | | | | □ 现场参观 | | | | | | √其他（ 2022 | 深圳辖区上市公司投资者网上集体接待日活动） | | | | | 通过"全景路演"网站（ | http://rs.p5w.net | | ）或微信公众号：全景 | | 参与单位名称及 人员姓名 | 财经或全景路演 APP | ，参与本次投资者网上集体接待日活 ...

证券代码：002980 证券简称：华盛昌 公告编号：2022-074 深圳市华盛昌科技实业股份有限公司 关于参加深圳辖区上市公司 2022 年投资者网上集体接待日活动的公告 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，深圳市华盛昌科技实业股份有限公司 （以下简称"公司"）将参加由深圳证监局指导、深圳上市公司协会与深圳市全 景网络有限公司联合举办的"2022年深圳辖区上市公司投资者集体接待日活动"， 现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演APP，参与 本次互动交流，活动时间为2022年11月9日（周三）16:30-17:30。届时公司高管将 在线就公司业绩、公司治理、发展战略、经营状况等投资者关心的问题，与投资 者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 深圳市华盛昌科技实业股份有限公司 董事会 2022 年 11 月 5 日 ...

深圳市华盛昌科技实业股份有限公司 2022 年第三季度报告 证券代码：002980 证券简称：华盛昌 公告编号：2022-073 深圳市华盛昌科技实业股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 147,041,424.15 | -24.48% | 466,898,314.17 | -15.38% | | 归属于上市公司股东的 净利润（元） | 34,592,848.05 | -22.82% | 95,927,582.48 | -26.62% | | 归属于上市公司股东的 扣除非经常性损益的净 | 31,392,891.10 | -18.08% | 87,459,957.15 | -24.75 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥319,856,890.02, a decrease of 10.41% compared to ¥357,034,426.53 in the same period last year[20] - Net profit attributable to shareholders was ¥61,334,734.43, down 28.60% from ¥85,905,121.28 year-on-year[20] - The net cash flow from operating activities was negative at -¥2,727,680.93, a decline of 111.07% compared to ¥24,635,777.70 in the previous year[20] - Basic earnings per share decreased to ¥0.46, down 28.13% from ¥0.64 in the same period last year[20] - Total assets at the end of the reporting period were ¥1,124,760,816.87, a decrease of 5.99% from ¥1,196,465,650.69 at the end of the previous year[20] - The gross margin for the instrument manufacturing industry was 36.94%, down by 4.19% from the previous year, indicating a decline in profitability[104] - The company reported a significant drop in net cash flow from operating activities, decreasing by 111.07% to -¥2.73 million from ¥24.64 million in the previous year[102] Revenue Breakdown - The sales revenue from the electrical power category was ¥172.15 million, accounting for 53.82% of total revenue, with a decrease of 6.36% year-on-year[103] - The environmental monitoring segment saw a revenue decline of 22.46%, totaling ¥76.19 million, which represented 23.82% of total revenue[103] - The company achieved a remarkable 386.64% increase in revenue from other business segments, reaching ¥14.97 million compared to ¥3.08 million in the previous year[103] - The overseas revenue accounted for 89.76% of total sales, amounting to ¥287.10 million, with a decrease of 8.95% year-on-year[103] Research and Development - The company increased R&D expenses by ¥7,457,000, contributing to the decline in net profit[21] - The company’s R&D investment increased by 35.02% to ¥28.75 million, up from ¥21.30 million, reflecting a continuous effort in developing new products and technologies[102] - The company has been deeply engaged in the measurement and testing industry for 31 years, focusing on technology research and product manufacturing across various sectors including power, electronics, and healthcare[30] - The company has implemented a dual-driven strategy of "technology + market" to enhance its market presence and product innovation, aiming to expand into emerging markets such as medical testing and new energy[31] Product Development and Innovation - The company has developed a high-end "A" level three-phase power quality analyzer, which supports 50Hz/60Hz grid frequency system measurements and can record and analyze various power quality parameters with a measurement accuracy of 0.1%[34] - The company introduced the first domestic all-in-one digital multimeter with an integrated thermal imaging function, achieving a DC voltage accuracy of 0.09%[34] - The company has launched a digital insulation tester that combines thermal imaging and low-resistance measurement capabilities, with an insulation test voltage output of 1000V and a measurement range of up to 5GΩ[34] - The company emphasizes the importance of IoT communication features in its products, allowing for real-time data sharing and analysis through smart terminal applications[34] - The company has reported a significant focus on the development of new products for the photovoltaic power generation sector, including devices capable of measuring up to 2000A current and 1500V DC voltage, fully compliant with EU safety standards[35] Market Strategy and Expansion - The company is actively responding to national strategies for "carbon peak and carbon neutrality," expanding its business into outdoor mobile power and home energy storage solutions[32] - The company is focused on expanding its market presence in sectors such as energy conservation, rail transportation, and petrochemical refining[34] - The company aims to enhance its product offerings through continuous innovation and development in precision electronic measurement tools for various industrial applications[35] - The company is focused on enhancing its product offerings in the energy and environmental sectors, aligning with trends in renewable energy and smart technology[40] Financial Management and Investments - The company has established a comprehensive service capability that enhances operational efficiency and economic benefits for clients through customized product development[97] - The total amount of funds raised by the company is 496.33 million CNY, with net proceeds of 454.27 million CNY after deducting issuance costs of 42.07 million CNY[119] - The company has established a foreign exchange hedging management system to mitigate risks associated with exchange rate fluctuations[117] - The company’s derivative investments are valued at fair value, based on prices provided by banks, ensuring accurate financial reporting[117] Corporate Governance and Compliance - The company emphasizes the protection of shareholder rights, ensuring timely and accurate information disclosure to all shareholders[142] - The company has established a complete internal control system to safeguard the interests of minority shareholders[142] - The company strictly adheres to environmental regulations and has not faced any administrative penalties during the reporting period[140] - The company has not engaged in any related party transactions during the reporting period, ensuring transparency and compliance[156] Social Responsibility and Community Engagement - The company actively engages in social responsibility, contributing to charitable causes such as donations for COVID-19 prevention materials[146] - The company has established partnerships with well-known listed companies in the livestock industry, effectively reducing costs and improving breeding efficiency[47] Risks and Challenges - The company faces risks from international trade policies and exchange rate fluctuations, which may impact future overseas business performance[130] - The company acknowledges market competition risks but maintains advantages in technology, R&D, and customer responsiveness[132] - The company is addressing raw material price volatility risks by optimizing supply chain resources and improving procurement strategies[131]

Financial Performance - The company's operating revenue for 2021 was ¥740,051,644.74, a decrease of 23.12% compared to ¥962,660,824.57 in 2020[20] - The net profit attributable to shareholders for 2021 was ¥148,888,059.88, down 55.89% from ¥337,558,995.59 in 2020[20] - The net cash flow from operating activities was ¥32,545,946.89, representing an 88.99% decline from ¥295,572,015.67 in the previous year[20] - Basic earnings per share for 2021 were ¥1.12, a decrease of 59.42% compared to ¥2.76 in 2020[20] - The total assets at the end of 2021 were ¥1,196,465,650.69, a slight increase of 0.46% from ¥1,190,985,051.58 at the end of 2020[21] - The net assets attributable to shareholders at the end of 2021 were ¥1,062,074,049.72, up 0.41% from ¥1,057,765,071.43 in 2020[21] - The weighted average return on equity for 2021 was 14.06%, down 26.49% from 40.55% in 2020[20] - The net profit after deducting non-recurring gains and losses for 2021 was ¥130,489,628.25, a decrease of 59.62% from ¥323,190,536.67 in 2020[20] Market and Product Development - The company is focusing on expanding its domestic market in response to the accelerating process of domestic substitution in the instrumentation industry[31] - The "dual carbon" goals are expected to create more market opportunities for the company's environmental monitoring products and solutions[32] - The company has established a biological medical laboratory to capture new opportunities in the healthcare sector, expanding from temperature measurement products to home healthcare and in vitro diagnostics[33] - The company is developing smart wearable products with detection functions to meet the growing demand for intelligent consumer electronics[34] - The company has a strong presence in the electronic power testing instrument sector, with significant advantages in overseas markets[38] - The company has been continuously innovating and leading the industry in measurement and testing solutions, leveraging 30 years of technical expertise[36] - The company has over 500 models of electronic power DIY products, maintaining stable and rapid growth in the measurement instrument sector, particularly in portable voltage testers, which have gained significant market share in the US[39] Sales and Revenue Insights - The company achieved a total revenue of 740.05 million yuan in 2021, representing a growth of 58.96% compared to the pre-pandemic year of 2019[37] - The net profit attributable to shareholders was 148.88 million yuan, which is a 63.68% increase from 2019[37] - Sales revenue from non-epidemic products grew by 31.91% year-on-year and by 46.64% compared to the same period in 2019[37] - The average gross profit margin for the company's products was 40.25%, with a net profit margin of 20.12%, indicating strong profitability[37] Research and Development - The company has established a joint laboratory with Southern University of Science and Technology, achieving significant results in MEMS gas sensor development[65] - The company plans to increase R&D investment in MEMS sensors and modules, anticipating broad market prospects in the IoT and consumer electronics sectors[65] - The company has developed a range of innovative products, including multifunctional multimeters and non-contact body temperature measurement devices, responding quickly to market demands[73] - The company has established a comprehensive quality management system aligned with national standards, ensuring high precision and reliability in its products[74] Operational Challenges and Risks - The company reported that there is uncertainty regarding its ability to continue as a going concern, as indicated in the audit report[21] - The company faces risks from international trade policies and exchange rate fluctuations, impacting overseas business performance[139] - Rising raw material prices pose a risk to manufacturing costs, prompting the company to optimize supply chain resources and control expenses[140] - The company recognizes market competition risks but maintains advantages in technology, R&D, and customer responsiveness[141] Corporate Governance - The company held three shareholder meetings during the reporting period, ensuring compliance with legal requirements and protecting shareholder rights[148] - The company has a board of directors consisting of 8 members, including 3 independent directors, complying with relevant laws and regulations[150] - The supervisory board comprises 3 members, including 1 employee representative, and has held 5 meetings during the reporting period[151] - The company maintains independent operations in terms of assets, personnel, finance, and business, ensuring no interference from the controlling shareholder[156] Employee and Management Structure - The total number of employees at the end of the reporting period was 1,357, with 1,294 in the parent company and 63 in major subsidiaries[190] - The professional composition included 983 production personnel, 114 sales personnel, 172 technical personnel, 25 financial personnel, and 63 administrative personnel[190] - The company has a diverse board with members holding various academic and professional backgrounds, including finance, engineering, and law[171] - The company has maintained a stable management team, with no significant changes in executive positions reported during the period[166] Profit Distribution and Financial Management - The proposed profit distribution plan for 2021 is to distribute a cash dividend of RMB 11 per 10 shares, totaling RMB 146,666,740 (including tax)[198] - The total distributable profit as of December 31, 2021, was RMB 273,974,037.60, with the cash dividend accounting for 100% of the profit distribution[196][198] - The company has established a stable profit distribution policy to ensure reasonable returns to investors, complying with relevant laws and regulations[194] - The cash dividend distribution plan was approved by the board and shareholders, ensuring transparency and adherence to corporate governance standards[195]

Financial Performance - The company's revenue for Q1 2022 was ¥148,818,081.86, a decrease of 9.49% compared to ¥164,423,521.31 in the same period last year[4] - Net profit attributable to shareholders was ¥25,385,849.65, down 37.36% from ¥40,523,552.79 year-on-year[4] - Operating profit decreased to ¥28,427,318.88 from ¥46,345,690.94, a decline of approximately 38.7%[20] - Net profit for the current period is ¥25,398,014.36, down from ¥40,546,036.69, indicating a decrease of about 37.3%[20] - Total comprehensive income for the current period is ¥25,069,325.71, down from ¥40,474,612.45, indicating a decrease of approximately 38.0%[21] - The basic earnings per share decreased to ¥0.19 from ¥0.30, a decline of about 36.7%[21] Cash Flow and Liquidity - The net cash flow from operating activities increased by 178.43% to ¥14,801,980.57, compared to ¥5,316,218.05 in the previous year[4] - The net increase in cash and cash equivalents was -¥48,329,364.77, a decline of 161.25% compared to an increase of ¥78,906,644.97 in the previous year[9] - Cash and cash equivalents at the end of the period decreased to ¥362,580,937.40 from ¥445,744,424.78, a decline of about 18.6%[25] - The company reported a net cash outflow from investing activities of ¥58,572,725.26, compared to a net inflow of ¥78,343,379.99 in the previous period[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,206,519,955.04, a slight increase of 0.84% from ¥1,196,465,650.69 at the end of the previous year[5] - The company's total liabilities decreased to CNY 118,497,641.82 from CNY 134,056,286.50 at the beginning of the year, indicating a reduction of approximately 11.6%[17] - The total current liabilities decreased to CNY 95,529,360.19 from CNY 120,831,373.62, a decrease of approximately 20.9%[16] - Cash and cash equivalents decreased to CNY 363,590,345.73 from CNY 411,919,710.50, representing a decline of approximately 11.7%[15] - The company's inventory increased to CNY 267,637,388.19 from CNY 253,044,261.01, marking an increase of about 5.8%[15] - The accounts receivable decreased to CNY 112,898,277.97 from CNY 124,545,618.26, a reduction of approximately 9.4%[15] Investment and Research - Research and development expenses increased by ¥2,159,000, reflecting a significant investment in innovation[5] - Research and development expenses increased to ¥12,321,559.88 from ¥10,162,534.49, reflecting a rise of approximately 21.2%[20] - Investment income rose by 433.93% to ¥456,841.57, attributed to gains from the disposal of financial products[9] - The company reported a significant increase in intangible assets, rising to CNY 33,652,453.51 from CNY 4,744,547.48, which is an increase of over 608%[16] Future Outlook - The company has plans for future product development and market expansion, focusing on innovative technologies and strategic partnerships[13] - The company received CE certification for its COVID-19 antigen rapid test kit, enhancing its product portfolio and market competitiveness[13]